Indefinite Delivery Contract 36C25024D0018
- Not listed
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory instruments, was awarded a Federal Supply Schedule contract by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on March 16, 2017, with an ultimate completion date of March 15, 2027. This multiple-award, open competition contract carries a ceiling value of $260,000,000.01 and was established under the General Services Administration's Critical Analyzers,...
- The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
- The federal agency, the Department of Veterans Affairs Veterans Health Administration (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The IDC has a ceiling value of $667,159.30 and an ultimate completion date of August 31, 2030, for the provision of REAGENTS AND CONSUMABLES. Under this IDC, a $135,281.86...
- Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract has a potential value of $1,115,564.58 to provide reagents and supplies with no set-aside designation. Performance will take place through January 31, 2028. Under this contract, Roche Diagnostics was issued a $210,121.69 firm fixed price delivery order for reagents and supplies. The delivery...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
- The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
- The Department of Veterans Affairs (VA) awarded Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics and medical laboratory equipment, an Indefinite Delivery Contract (IDC) valued at $2,821,000.00. The contract covers the provision of ROCHE CONSUMABLES, including diagnostic test kits, reagents, and laboratory instruments, to support medical testing services at VA facilities. Roche Diagnostics holds multiple IDCs and Blanket Purchase Agreements (BPAs) with the VA and...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Roche Diagnostics Corporation an indefinite delivery contract with a potential value of $773,160 to provide COVID-19 reagents. Under this contract, Roche was issued a firm fixed price delivery order worth $345,452.54 to supply COVID-19 test kits and materials for use in Castleton, Indiana, with delivery required by November 30, 2020. The original solicitation sought diagnostic test...
- The Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The contract, valued at up to $2,000,000, covers the delivery of CTX respiratory pathogen testing capabilities to the VA's Veterans Integrated Service Network 17 from July 2023 through June 2028. Under this IDC, the VA has issued multiple firm-fixed-price delivery...
- 36C25024D0018Indefinite Delivery Contract
- 2Federal Contract Awards
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has provided critical laboratory equipment, reagents, and associated products and services to the VA, DoD, HHS, and other agencies through IDCs, blanket purchase agreements, and subcontracts. The original solicitation by the Richard L. Roudebush VA Medical Center seeks to lease three rapid PCR analyzers capable of processing SARS-CoV-2, influenza A/B, and RSV test results in under 25 minutes to support testing of symptomatic and asymptomatic patients at the medical center in Indianapolis, Indiana. The base period is one year with two one-year option periods, and the vendor will be responsible for installation, integration, providing reagents and supplies, and maintenance over the potential three-year period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/21/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25024D0018-36C25025N0325 | Roche Diagnostics Corporation | $33.6k | 3/1/25 | 2/28/26 | 1/24/25 | |
Delivery Order 36C25024D0018-36C25024N0388 | Roche Diagnostics Corporation | $72.0k | 3/1/24 | 3/21/25 | 3/21/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6640--Rapid PCR Analyzers and Reagents, Base plus Two Years Indianapolis VA Medical Center SARS-CoV-2 and Influenza Testing | 36C25024Q0137 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 | Pre-Solicitation 1/2 | 11/30/23, 12:24 PM | |
6640--Supplies, LIAT Rapid PCR Analyzers B+2, IND (03/01) | 36C25024Q0137 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 | Award Notice 2/2 | 2/29/24, 10:07 AM |